Separate terms with OR to return results that match either term.
 
Clear All

10,000 Matching ResultsExport these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category (Ascending) Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
00143-9553-01 00143-9553 Leucovorin Calcium Leucovorin Calcium 200.0 mg/20mL Ancillary Therapy Chemoprotective Antidote Intramuscular, Intravenous May 23, 1995 In Use
67457-0530-35 67457-0530 LEUCOVORIN CALCIUM LEUCOVORIN CALCIUM 350.0 mg/17.5mL Ancillary Therapy Chemoprotective Antidote Intramuscular, Intravenous Jan. 2, 2019 In Use
68083-0278-01 68083-0278 Levoleucovorin levoleucovorin 10.0 mg/mL Ancillary Therapy Chemoprotective Antidote Intravenous Sept. 20, 2018 In Use
68083-0279-01 68083-0279 Levoleucovorin levoleucovorin 10.0 mg/mL Ancillary Therapy Chemoprotective Antidote Intravenous Sept. 20, 2018 In Use
72266-0123-25 72266-0123 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous April 2, 2019 In Use
59572-0711-01 59572-0711 Luspatercept REBLOZYL 25.0 mg/1 Ancillary Therapy Erythropoiesis-Stimulating Agent Subcutaneous Nov. 8, 2019 In Use
55513-0014-01 55513-0014 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Oct. 1, 2001 Feb. 28, 2009 No Longer Used
55513-0015-01 55513-0014 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Aug. 19, 2002 April 30, 2009 No Longer Used
55513-0039-01 55513-0039 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Feb. 18, 2011 Feb. 28, 2009 No Longer Used
55513-0039-04 55513-0039 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent July 23, 2003 Feb. 28, 2009 No Longer Used
55513-0041-01 55513-0041 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Feb. 18, 2011 Feb. 28, 2009 No Longer Used
55513-0041-04 55513-0041 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent July 23, 2003 Feb. 28, 2009 No Longer Used
55513-0043-01 55513-0043 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Feb. 18, 2011 Dec. 31, 2008 No Longer Used
55513-0043-04 55513-0043 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent June 1, 2004 Dec. 31, 2008 No Longer Used
55513-0044-01 55513-0044 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Feb. 18, 2011 Feb. 28, 2009 No Longer Used
55513-0044-04 55513-0044 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent July 23, 2003 Feb. 28, 2009 No Longer Used
55513-0046-01 55513-0046 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Feb. 18, 2011 April 30, 2009 No Longer Used
55513-0046-04 55513-0046 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent July 23, 2003 April 30, 2009 No Longer Used
51079-0520-01 51079-0520 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Oct. 22, 2007 Aug. 31, 2015 No Longer Used
51079-0520-20 51079-0520 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Oct. 22, 2007 Aug. 31, 2015 No Longer Used
51079-0520-30 51079-0520 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Oct. 22, 2007 Aug. 31, 2015 No Longer Used
51079-0520-56 51079-0520 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Oct. 26, 2009 July 31, 2015 No Longer Used
52125-0606-02 52125-0606 Finasteride Finasteride Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral May 29, 2013 March 11, 2014 No Longer Used
52125-0606-19 52125-0606 Finasteride Finasteride Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Sept. 19, 2013 Sept. 19, 2013 No Longer Used
52152-0500-02 52152-0500 Finasteride Finasteride Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral March 28, 2007 Sept. 30, 2013 No Longer Used
52152-0500-08 52152-0500 Finasteride Finasteride Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Jan. 10, 2011 Sept. 30, 2013 No Longer Used
52152-0500-30 52152-0500 Finasteride Finasteride Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral March 28, 2007 Sept. 30, 2013 No Longer Used
63629-1585-01 63629-1585 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Oct. 30, 2007 Feb. 28, 2017 No Longer Used
63629-1585-02 63629-1585 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Oct. 30, 2007 Feb. 28, 2017 No Longer Used
63629-1585-03 63629-1585 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Oct. 30, 2007 Feb. 28, 2017 No Longer Used
63629-1585-04 63629-1585 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Oct. 30, 2007 Feb. 28, 2017 No Longer Used
55390-0250-10 55390-0250 Granisetron Hydrochloride Granisetron Hydrochloride Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist July 28, 2008 Nov. 30, 2009 No Longer Used
58160-0830-01 58160-0830 Human Papillomavirus Bivalent Vaccine, Recombinant Cervarix 20.0 ug/.5mL, 20.0 ug/.5mL Ancillary Therapy Protective Agent HPV Vaccine Intramuscular Oct. 16, 2009 Aug. 24, 2012 No Longer Used
58160-0830-05 58160-0830 Human Papillomavirus Bivalent Vaccine, Recombinant Cervarix 20.0 ug/.5mL, 20.0 ug/.5mL Ancillary Therapy Protective Agent HPV Vaccine Intramuscular March 20, 2012 Nov. 29, 2016 No Longer Used
58160-0830-11 58160-0830 Human Papillomavirus Bivalent Vaccine, Recombinant Cervarix 20.0 ug/.5mL, 20.0 ug/.5mL Ancillary Therapy Protective Agent HPV Vaccine Intramuscular Oct. 16, 2009 Aug. 24, 2012 No Longer Used
58160-0830-32 58160-0830 Human Papillomavirus Bivalent Vaccine, Recombinant Cervarix 20.0 ug/.5mL, 20.0 ug/.5mL Ancillary Therapy Protective Agent HPV Vaccine Intramuscular Oct. 16, 2009 Sept. 3, 2013 No Longer Used
58160-0830-34 58160-0830 Human Papillomavirus Bivalent Vaccine, Recombinant Cervarix 20.0 ug/.5mL, 20.0 ug/.5mL Ancillary Therapy Protective Agent HPV Vaccine Intramuscular March 20, 2012 Nov. 29, 2016 No Longer Used
58160-0830-41 58160-0830 Human Papillomavirus Bivalent Vaccine, Recombinant Cervarix 20.0 ug/.5mL, 20.0 ug/.5mL Ancillary Therapy Protective Agent HPV Vaccine Intramuscular July 25, 2011 Sept. 3, 2013 No Longer Used
58160-0830-43 58160-0830 Human Papillomavirus Bivalent Vaccine, Recombinant Cervarix 20.0 ug/.5mL, 20.0 ug/.5mL Ancillary Therapy Protective Agent HPV Vaccine Intramuscular July 25, 2011 Nov. 29, 2016 No Longer Used
58160-0830-46 58160-0830 Human Papillomavirus Bivalent Vaccine, Recombinant Cervarix 20.0 ug/.5mL, 20.0 ug/.5mL Ancillary Therapy Protective Agent HPV Vaccine Intramuscular Oct. 16, 2009 Sept. 3, 2013 No Longer Used
58160-0830-52 58160-0830 Human Papillomavirus Bivalent Vaccine, Recombinant Cervarix 20.0 ug/.5mL, 20.0 ug/.5mL Ancillary Therapy Protective Agent HPV Vaccine Intramuscular July 25, 2011 Nov. 29, 2016 No Longer Used
43288-0104-01 43288-0104 Ondansetron Zuplenz Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral July 5, 2010 Nov. 16, 2013 No Longer Used
43288-0104-10 43288-0104 Ondansetron Zuplenz Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral July 5, 2010 Nov. 30, 2015 No Longer Used
43288-0108-01 43288-0108 Ondansetron Zuplenz Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral July 5, 2010 Nov. 16, 2013 No Longer Used
43288-0108-10 43288-0108 Ondansetron Zuplenz Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral July 5, 2010 Nov. 30, 2015 No Longer Used
49349-0858-08 49349-0858 Ondansetron Zofran 8.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Dec. 19, 2011 Oct. 25, 2016 No Longer Used
49884-0324-11 49884-0324 Ondansetron Zuplenz Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral July 5, 2010 Sept. 15, 2011 No Longer Used
49884-0324-52 49884-0324 Ondansetron Zuplenz Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral July 5, 2010 Sept. 15, 2011 No Longer Used
49884-0324-62 49884-0324 Ondansetron Zuplenz Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral July 5, 2010 Nov. 30, 2012 No Longer Used
49884-0325-11 49884-0325 Ondansetron Zuplenz Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral July 5, 2010 Nov. 11, 2011 No Longer Used

Found 10,000 results in 4 millisecondsExport these results